Pilot Study of a New Mathematical Algorithm for Early Detection of Late-Onset Sepsis in Very Low-Birth-Weight Infants

Abstract

Background Diagnosis of late onset sepsis (LOS) in very low birth weight (VLBW) preterm infants relies mainly on clinical suspicion, whereas prognosis depends on early initiation of antibiotic treatment. RALIS is a mathematical algorithm for early detection of LOS incorporating six vital signs measured every 2 hours.

Objective The aim of this study is to study RALIS ability to detect LOS before clinical suspicion.

Study Design A total of 118 VLBW preterm infants (gestational age < 33 weeks, birth weight < 1,500 g) were enrolled in a prospective multicentered study. Vital signs were recorded prospectively up to day 21 of life in a blinded manner, with no effect on standard care. The primary end point was comparison of the rates and timing of detection of LOS between RALIS and clinical/culture evidence of LOS.

Results Of the 2,174 monitoring days, RALIS indicated sepsis in 590 days, and LOS was positively diagnosed in 229 days. Sensitivity, specificity, positive, and negative predictive values were 74.6, 80.7, 38.8, and 95.1%, respectively. RALIS provided an indication for sepsis 3 days on the average before clinical suspicion.

Conclusion RALIS has a promising potential as an easy to implement noninvasive early indicator of LOS, especially for ruling out LOS in VLBW high-risk infants.

Keywords

sepsis - premature infant - very low-birth-weight infant - morbidity - mortality

• References

• 1 Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51 (4) 939-959 , viii–ix
• 2 Sivanandan S, Soraisham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr 2011; 2011: 712150
• 3 Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002; 109 (1) 34-39
• 4 Stoll BJ, Hansen N, Fanaroff AA , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110 (2 Pt 1) 285-291
• 5 Fanaroff AA, Korones SB, Wright LL , et al; The National Institute of Child Health and Human Development Neonatal Research Network. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Pediatr Infect Dis J 1998; 17 (7) 593-598
• 6 Morioka I, Morikawa S, Miwa A , et al. Culture-proven neonatal sepsis in Japanese neonatal care units in 2006-2008. Neonatology 2012; 102 (1) 75-80
• 7 Hornik CP, Fort P, Clark RH , et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88 (Suppl. 02) S69-S74
• 8 Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. National Nosocomial Infections Surveillance System. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996; 98 (3 Pt 1) 357-361
• 9 Polin RA. Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129 (5) 1006-1015
• 10 Lukaszewski RA, Yates AM, Jackson MC , et al. Presymptomatic prediction of sepsis in intensive care unit patients. Clin Vaccine Immunol 2008; 15 (7) 1089-1094
• 11 Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]. Crit Care 2004; 8 (6) R443-R450
• 12 Claeys R, Vinken S, Spapen H , et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30 (4) 757-762
• 13 Berner R, Niemeyer CM, Leititis JU , et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998; 44 (4) 469-477
• 14 Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17 (10) 975-978
• 15 Damas P, Ledoux D, Nys M , et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215 (4) 356-362
• 16 Fujishima S, Sasaki J, Shinozawa Y , et al. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 1996; 22 (11) 1169-1175
• 17 Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995; 86 (10) 3841-3847
• 18 Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996; 40 (4) 613-616 , discussion 616–617
• 19 Hotoura E, Giapros V, Kostoula A, Spyrou P, Andronikou S. Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis. Inflammation 2012; 35 (3) 1094-1101
• 20 Raynor LL, Saucerman JJ, Akinola MO, Lake DE, Moorman JR, Fairchild KD. Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res 2012; 71 (3) 261-266
• 21 Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26 (Suppl. 02) S148-S152
• 22 Müller B, Becker KL, Schächinger H , et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28 (4) 977-983
• 23 Neely AN, Fowler LA, Kagan RJ, Warden GD. Procalcitonin in pediatric burn patients: an early indicator of sepsis?. J Burn Care Rehabil 2004; 25 (1) 76-80
• 24 Kabir K, Keller H, Grass G , et al. Cytokines and chemokines in serum and urine as early predictors to identify septic patients on intensive care unit. Int J Mol Med 2003; 12 (4) 565-570
• 25 Toh CH, Ticknor LO, Downey C, Giles AR, Paton RC, Wenstone R. Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Implications of lipoprotein-complexed C reactive protein formation. Intensive Care Med 2003; 29 (1) 55-61
• 26 Calvano SE, Xiao W, Richards DR , et al; Inflamm and Host Response to Injury Large Scale Collab. Res. Program. A network-based analysis of systemic inflammation in humans. Nature 2005; 437 (7061) 1032-1037
• 27 Fairchild KD, Aschner JL. HeRO monitoring to reduce mortality in NICU patients. J Res Rep Neonatol 2012; 2: 65-76
• 28 Moorman JR, Carlo WA, Kattwinkel J , et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr 2011; 159 (6) 900-906 , e1
• 29 Groves AM, Edwards AD. Heart rate characteristic monitoring-HeRO or villain?. J Pediatr 2011; 159 (6) 885-886